The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-80
SponsorKing Chulalongkorn Memorial Hospital

About this trial

The goal of this observational study is to learn about the carbon footprint produced from diagnostic upper GI endoscopy in patients with dyspepsia and therapeutic upper GI endoscopy in patients with non-variceal upper GI bleeding. The main question it aims to answer is:

• How much carbon footprint is generated from upper GI endoscopy Participants are already receiving diagnostic and therapeutic upper GI endoscopy as part of their regular medical care for dyspepsia and non-variceal upper GI bleeding, respectively. The carbon footprint generated from this treatment process is examined.

Eligibility criteria

Qualifiers

Patients with dyspepsia or non-variceal upper GI bleeding

Age 20-80 years

Body mass index of 30 or less;

Disqualifiers

Platelet < 50,000

INR > 2.5

Pregnancy

History of allergy to IV sedative medication

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

75 Participants
are grouped into 2 trial groups